Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ajmaline in the diagnosis and treatment of cardiac arrhythmias
2007-006334-33Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Jan 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ajmaline in Atrial fibrillation (AFib) and ventricular tachycardia (VT) (4 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Proportion of patients with reversal of atrial fibrillation. Started Jan 2008; status: completed.
02
Drugs
ajmaline
03
Conditions
Atrial fibrillation (AFib)ventricular tachycardia (VT)
Beyond the preview
Go deeper on 2007-006334-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006334-33.